Lineage Cell Therapeutics Inc (AMEX:LCTX) has a beta value of 1.42 and has seen 1.33 million shares traded in the last trading session. The company, currently valued at $100.48M, closed the last trade at $0.44 per share which meant it lost -$0.03 on the day or -6.38% during that session. The LCTX stock price is -184.09% off its 52-week high price of $1.25 and 15.91% above the 52-week low of $0.37.
Lineage Cell Therapeutics Inc (AMEX:LCTX) trade information
Sporting -6.38% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the LCTX stock price touched $0.44 or saw a rise of 10.2%. Year-to-date, Lineage Cell Therapeutics Inc shares have moved -12.44%, while the 5-day performance has seen it change -10.33%. Over the past 30 days, the shares of Lineage Cell Therapeutics Inc (AMEX:LCTX) have changed 6.13%.
Lineage Cell Therapeutics Inc (LCTX) estimates and forecasts
The company’s shares have lost -47.90% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 18.72%.
7 analysts offering their estimates for the company have set an average revenue estimate of 1.72M for the current quarter. 7 have an estimated revenue figure of 1.72M for the next ending quarter. Year-ago sales stood 1.44M and 1.41M respectively for this quarter and the next, and analysts expect sales will grow by 19.11% for the current quarter and 18.72% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -2.93% over the past 5 years.
LCTX Dividends
Lineage Cell Therapeutics Inc is expected to release its next earnings report in June this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Lineage Cell Therapeutics Inc (AMEX:LCTX)’s Major holders
The top two institutional holders are BROADWOOD CAPITAL INC with over 41.67 million shares worth more than $41.55 million. As of 2024-06-30, BROADWOOD CAPITAL INC held 22.0675% of shares outstanding.
The other major institutional holder is BLACKROCK INC., with the holding of over 9.56 million shares as of 2024-06-30. The firm’s total holdings are worth over $9.53 million and represent 5.0629% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are iShares Trust-iShares Russell 2000 ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . As of Mar 31, 2025 , the former fund manager holds about 1.98% shares in the company for having 4.53 shares of worth $1.99 million while later fund manager owns 4.42 shares of worth $1.94 million as of Dec 31, 2024 , which makes it owner of about 1.93% of company’s outstanding stock.
